ConductScience.org, home

Paper20176903

Compensation of fitness costs and reversibility of antibiotic resistance mutations.

Schulz zur Wiesch P and 2 others. Antimicrob Agents Chemother, 2010. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. Compensation of fitness costs and reversibility of antibiotic resistance mutations. Papers, record 20176903. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20176903

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Compensation of fitness costs and reversibility of antibiotic resistance mutations.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
3.15
iCite
Revised in PubMed
2021-10-20
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schulz zur Wiesch PPia
2Engelstädter JJan
3Bonhoeffer SSebastian

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
Biological EvolutionMajor topic
Drug Resistance, BacterialMajor topic
Models, GeneticMajor topic
Adaptation, Physiological
Extinction, Biological
Genotype
Mutation

Source PubMed

Download CSV of topics

References81

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115216466Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.J Infect Dis2004https://conductscience.org/library/papers/15216466PubMed
214572536Persistence of antibiotic resistant bacteria.Curr Opin Microbiol2003https://conductscience.org/library/papers/14572536PubMed
311717398Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11717398PubMed
46760797The shifting balance theory and macroevolution.Annu Rev Genet1982https://conductscience.org/library/papers/6760797PubMed
519713526Functional characterization of the antibiotic resistance reservoir in the human microflora.Science2009https://conductscience.org/library/papers/19713526PubMed
616415927Long-term survival during stationary phase: evolution and the GASP phenotype.Nat Rev Microbiol2006https://conductscience.org/library/papers/16415927PubMed
72326763Some models of neutral evolution, compensatory evolution, and the shifting balance process.Theor Popul Biol1990https://conductscience.org/library/papers/2326763PubMed
819056402Exploring the role of the immune response in preventing antibiotic resistance.J Theor Biol2009https://conductscience.org/library/papers/19056402PubMed
916714138Fitness of antimicrobial-resistant Campylobacter and Salmonella.Microbes Infect2006https://conductscience.org/library/papers/16714138PubMed
1010639349Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10639349PubMed
1112505030Mutation rate and the efficacy of antimicrobial drug treatment.Lancet Infect Dis2003https://conductscience.org/library/papers/12505030PubMed
1210858329Mutation frequencies and antibiotic resistance.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10858329PubMed
1317458569Reversion of resistance in relapsing infection caused by a glycopeptide-intermediate methicillin-resistant Staphylococcus aureus isolate.Eur J Clin Microbiol Infect Dis2007https://conductscience.org/library/papers/17458569PubMed
1417987316Tuberculosis: drug resistance, fitness, and strategies for global control.Eur J Pediatr2008https://conductscience.org/library/papers/17987316PubMed
1515793122Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15793122PubMed
1618399718Modelling within-host spatiotemporal dynamics of invasive bacterial disease.PLoS Biol2008https://conductscience.org/library/papers/18399718PubMed
1716377711Heterogeneous macrolide resistance and gene conversion in the pneumococcus.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16377711PubMed
1818780736Secondary mutations correct fitness defects in Toxoplasma gondii with dinitroaniline resistance mutations.Genetics2008https://conductscience.org/library/papers/18780736PubMed
199869563Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/9869563PubMed
2011524714Minimizing potential resistance: a population dynamics view.Clin Infect Dis2001https://conductscience.org/library/papers/11524714PubMed

See all 81 referencesDownload CSV of references

Cited by76

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
42922472Parallel evolution under constraint shapes echinocandin resistance in Candida auris.bioRxiv2026https://conductscience.org/library/papers/42922472PubMed
42844390Predicting resistance evolution to guide antibiotic development.Nat Rev Microbiol2026https://conductscience.org/library/papers/42844390PubMed
42638747Patterns of Mycobacterium tuberculosis genotypes and resistance mutations in patients with pulmonary multidrug-resistant tuberculosis in Sverdlovsk Oblast, Russia.Front Tuberc2025https://conductscience.org/library/papers/42638747PubMed
42434557Molecular insights into antimicrobial resistance in human bacterial pathogens: mechanisms, resistance genes, and translational diagnostic applications.Front Microbiol2026https://conductscience.org/library/papers/42434557PubMed
42332064Modelling the role of the microbiome in antimicrobial resistance across scales.Nat Microbiol2026https://conductscience.org/library/papers/42332064PubMed
42069795Lifestyle-dependent evolution and CtrA-mediated lifestyle transitions shape phage resistance in marine Roseobacter.Nat Commun2026https://conductscience.org/library/papers/42069795PubMed
41291054Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemia.Sci Rep2025https://conductscience.org/library/papers/41291054PubMed
40968390Epidemiology and antimicrobial resistance of Salmonella enterica serotype Infantis in the United States: infections and emergence of a multidrug-resistant strain during 1979-2022.Infect Dis (Lond)2026https://conductscience.org/library/papers/40968390PubMed
40872298Core Perturbomes of Escherichia coli and Staphylococcus aureus Using a Machine Learning Approach.Pathogens2025https://conductscience.org/library/papers/40872298PubMed
40742148The diverse phenotypic and mutational landscape induced by fluoroquinolone treatment.mSystems2025https://conductscience.org/library/papers/40742148PubMed
40215274Epistasis-mediated compensatory evolution in a fitness landscape with adaptational tradeoffs.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40215274PubMed
39838279Fluoroquinolone-specific resistance trajectories in E. coli and their dependence on the SOS-response.BMC Microbiol2025https://conductscience.org/library/papers/39838279PubMed
39801834An eco-evolutionary perspective on antimicrobial resistance in the context of One Health.iScience2025https://conductscience.org/library/papers/39801834PubMed
39626761The emergence of nonlinear evolutionary trade-offs and the maintenance of genetic polymorphisms.Biol Lett2024https://conductscience.org/library/papers/39626761PubMed
39043246Context-dependent fitness benefits of antibiotic resistance mutations.Proc Biol Sci2024https://conductscience.org/library/papers/39043246PubMed
38988564Comparative fitness trade-offs associated with azole resistance in Candida auris clinical isolates.Heliyon2024https://conductscience.org/library/papers/38988564PubMed
38893378Upregulated Palmitoleate and Oleate Production in Escherichia coli Promotes Gentamicin Resistance.Molecules2024https://conductscience.org/library/papers/38893378PubMed
38853830The Emergence of Non-Linear Evolutionary Trade-offs and the Maintenance of Genetic Polymorphisms.bioRxiv2024https://conductscience.org/library/papers/38853830PubMed
38510041Unraveling resistance mechanisms in combination therapy: A comprehensive review of recent advances and future directions.Heliyon2024https://conductscience.org/library/papers/38510041PubMed
37840717The balance between antibiotic resistance and fitness/virulence in Pseudomonas aeruginosa: an update on basic knowledge and fundamental research.Front Microbiol2023https://conductscience.org/library/papers/37840717PubMed

See all 76 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20176903

GET https://conductscience.org/api/papers/v1/20176903/references?page=2